Menu
Menu
Question:
I was reviewing the archive and came across a Q&A related to modifier JW. That answer states that the modifier relates only to single-use vials—a vial of liquid medication intended for parenteral administration (injection or infusion) that is meant for use in a single patient for a single case, procedure or injection. This would seem to mean that the modifier would not apply to packages for non-liquid drugs. Is that correct?
Answer:
The JW modifier applies to single-dose vials, but it also applies to single-use packages for drugs and biologicals that would not be dispensed in liquid form. This is for something such as skin substitutes or other single-use products that are applied or implanted and not infused.
CPT® copyright 2023 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 5874 Blackshire Path, #13, Inver Grove Heights, MN 55076
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Copyright © 2024 MedLearn Publishing. Powered by MedLearn Media.
Happy World Health Day! Our exclusive webcast, ‘2024 SDoH Update: Navigating Coding and Screening Assessment,’ is just $99 for a limited time! Use code WorldHealth24 at checkout.